Related Experiment Videos
Significance of occult gastrointestinal bleeding during anticoagulation therapy
Insights
Anticoagulation therapy increases the risk of occult gastrointestinal bleeding. However, this bleeding often signals underlying intestinal disease rather than being caused by the anticoagulant medication itself.
Area of Science:
- Gastroenterology
- Hematology
- Internal Medicine
Background:
- Anticoagulation therapy is widely used for various medical conditions.
- The potential link between anticoagulation and gastrointestinal bleeding requires thorough investigation.
Purpose of the Study:
- To evaluate the prevalence of occult gastrointestinal bleeding in patients on anticoagulation.
- To identify the underlying causes of gastrointestinal bleeding in this patient group.
Main Methods:
- A prospective study involving 256 patients receiving anticoagulants.
- Screening for occult gastrointestinal bleeding using guaiac-impregnated cards.
- Comparison with a control group of 74 patients not on anticoagulation.
Main Results:
- Occult gastrointestinal bleeding was detected in 12% of patients on anticoagulation versus 3% in controls.
- No significant difference in prothrombin time or partial thromboplastin time between bleeding and non-bleeding anticoagulated patients.
- Undiagnosed intestinal lesions were found in 15 of 16 evaluated anticoagulated patients with bleeding.
Conclusions:
- Occult gastrointestinal bleeding in patients on anticoagulation is frequently indicative of significant intestinal disease.
- Bleeding should not be automatically attributed to anticoagulation; further diagnostic evaluation is warranted.
Abstract:
A prospective study was undertaken to determine the effect of anticoagulation therapy on the prevalence of occult gastrointestinal bleeding and to ascertain the causes of bleeding. During a six-month period, 256 patients who had received anticoagulants were screened for occult bleeding with guaiac-impregnated cards. Twenty-one (12 percent) of the 175 patients who had received anticoagulants and who voluntarily completed the cards had occult gastrointestinal bleeding compared with only two (3 percent) of 74 control patients who had not received anticoagulants. The mean prothrombin time and partial thromboplastin time did not differ significantly in the patients who had received anticoagulants with and without subsequent bleeding. Fifteen of 16 patients who had received anticoagulants and who underwent diagnostic evaluation had previously undiagnosed lesions in the intestinal tract. These results indicate that occult gastrointestinal bleeding in a patient who has received an anticoagulant should not be attributed to the anticoagulant; instead, such bleeding often indicates the presence of significant intestinal disease.